CervoMed - 53 Year Dividend History | CRVO

Historical dividend payout and yield for CervoMed (CRVO) since 1971. The current TTM dividend payout for CervoMed (CRVO) as of April 18, 2024 is $0.00. The current dividend yield for CervoMed as of April 18, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.154B $0.007B
CervoMed Inc. is a clinical-stage biotechnology company advancing CNS-focused therapeutics for patients with a range of degenerative diseases of the brain. The Company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant which inhibits p38MAP kinase alpha. CervoMed Inc., formerly known as Diffusion Pharmaceuticals Inc., is based in BOSTON.
Stock Name Country Market Cap PE Ratio